| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science Officer
1 company
Mark Mortenson is Chief Science Officer at CLNN. Mark Mortenson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $109K at current prices.
Net of sales, the CLNN filings show accumulation of 265 shares.
Mark Mortenson has 17 Form 4 filings on record from April 2021 to October 2026, all as Chief Science Officer at Clene (CLNN), 2021–2026.
The 19 reported transactions were 16 option or other derivative awards, 1 open-market purchase, 1 open-market sale and 1 stock award.
Counted by filing, the open-market trades come to 1 purchase worth about $97K and 1 sale worth about $50K.
The only open-market purchase was 20,512 shares of CLNN at an average $4.75 on September 30, 2024, about $97K. Twelve months later CLNN was up 31%.
The only open-market sale was 20,247 shares of CLNN at an average $2.47 on June 16, 2022, about $50K. Twelve months later CLNN was down 67%.